These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18051411)

  • 21. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
    Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
    Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of vorinostat: current applications and future perspectives for cancer therapy.
    Richon VM; Garcia-Vargas J; Hardwick JS
    Cancer Lett; 2009 Aug; 280(2):201-10. PubMed ID: 19181442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of the anti-cancer effects of histone deacetylase inhibitors.
    Epping MT; Bernards R
    Int J Biochem Cell Biol; 2009 Jan; 41(1):16-20. PubMed ID: 18765293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histone acetylation, gene regulation and depression].
    Vialou V
    Med Sci (Paris); 2010 May; 26(5):465-7. PubMed ID: 20510142
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents.
    Dong G; Wang L; Wang CY; Yang T; Kumar MV; Dong Z
    J Pharmacol Exp Ther; 2008 Jun; 325(3):978-84. PubMed ID: 18310471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDACi--going through the mechanisms.
    Wanczyk M; Roszczenko K; Marcinkiewicz K; Bojarczuk K; Kowara M; Winiarska M
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):340-59. PubMed ID: 21196174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone acetyltransferases and deacetylases: molecular and clinical implications to gastrointestinal carcinogenesis.
    Sun WJ; Zhou X; Zheng JH; Lu MD; Nie JY; Yang XJ; Zheng ZQ
    Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):80-91. PubMed ID: 22194016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET.
    Brest P; Gustafsson M; Mossberg AK; Gustafsson L; Duringer C; Hamiche A; Svanborg C
    Cancer Res; 2007 Dec; 67(23):11327-34. PubMed ID: 18056459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.
    Dallavalle S; Cincinelli R; Nannei R; Merlini L; Morini G; Penco S; Pisano C; Vesci L; Barbarino M; Zuco V; De Cesare M; Zunino F
    Eur J Med Chem; 2009 May; 44(5):1900-12. PubMed ID: 19084294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysine acetylation targets protein complexes and co-regulates major cellular functions.
    Choudhary C; Kumar C; Gnad F; Nielsen ML; Rehman M; Walther TC; Olsen JV; Mann M
    Science; 2009 Aug; 325(5942):834-40. PubMed ID: 19608861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs).
    Schäfer S; Saunders L; Eliseeva E; Velena A; Jung M; Schwienhorst A; Strasser A; Dickmanns A; Ficner R; Schlimme S; Sippl W; Verdin E; Jung M
    Bioorg Med Chem; 2008 Feb; 16(4):2011-33. PubMed ID: 18054239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase.
    Choudhury M; Shukla SD
    Alcohol Clin Exp Res; 2008 May; 32(5):829-39. PubMed ID: 18336638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epigenetics in hematological disorders].
    Furukawa Y
    Rinsho Ketsueki; 2008 Oct; 49(10):1472-82. PubMed ID: 18833931
    [No Abstract]   [Full Text] [Related]  

  • 34. A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation.
    Hardcastle A; Tomlin P; Norris C; Richards J; Cordwell M; Boxall K; Rowlands M; Jones K; Collins I; McDonald E; Workman P; Aherne W
    Mol Cancer Ther; 2007 Mar; 6(3):1112-22. PubMed ID: 17363504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
    Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
    J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors as anti-neoplastic agents.
    Batty N; Malouf GG; Issa JP
    Cancer Lett; 2009 Aug; 280(2):192-200. PubMed ID: 19345475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer treatment of the future: inhibitors of histone methyltransferases.
    Spannhoff A; Sippl W; Jung M
    Int J Biochem Cell Biol; 2009 Jan; 41(1):4-11. PubMed ID: 18773966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
    Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
    Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.